Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-04

Clinical Trial Update: Prevention of Photoparoxysmal Abnormalities by Mozart K448 [NA]

View source ↗

Summary

This clinical trial evaluating prevention of photoparoxysmal abnormalities by Mozart K448 in people with epilepsy and seizures was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medical University of South Carolina | Conditions: Photoparoxysmal Abnormalities, Epilepsy | NA | Status: TERMINATED